India's First Zika Vaccine Moves Closer to Human Trials After CDSCO Panel Recommendation
Developed by Indian Immunologicals Limited and Australia's Griffith University, the vaccine candidate has received an expert committee's recommendation for Phase I testing after additional safety and research documents were submitted.
By Simran PradeepUpdated








